MedPath

Low-dose Hydrocortisone in Acutely Burned Patients

Phase 4
Completed
Conditions
Burns
Registration Number
NCT00149123
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Major burns trigger the release of circulating mediators, as cytokines and endotoxin that induces a systemic inflammatory response syndrome. The cardiovascular effects are similar to those seen in septic shock. After the initial hypovolemic phase, patients with extensive burns often present a shock with increased cardiac output and reduced systemic vascular resistances. As described in septic shock, we test the hypothesis that low-dose hydrocortisone could decrease the duration of the shock period.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • males and females,
  • between 18 and 75 year old
  • who present a burned surface more than 30% of the body surface
  • who need catecholamine infusion
  • between J0 and J3 after the injury.
Exclusion Criteria
  • pregnancy,
  • trauma,
  • sepsis,
  • cardiac insufficiency,
  • AIDS,
  • etomidate administration

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of patients who do not receive any more catecholamine 4 days after the beginning of the shock
Secondary Outcome Measures
NameTimeMethod
Duration of catecholamine administration
Doses of administered catecholamine
Adrenal insufficiency incidence

Trial Locations

Locations (1)

Sylvie TISSOT

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath